Solventum Analyst Ratings
B of A Securities Maintains Neutral on Solventum, Lowers Price Target to $60
Solventum Corp: Goldman Sachs starts insurance with sale rating; target share price is $54
Solventum Analyst Ratings
Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target
Solventum (SOLV.US) was first covered by B of A Securities, which gave it a neutral rating, with a target price of $70.00.
Solventum Analyst Ratings
B of A Securities Initiates Coverage On Solventum With Neutral Rating, Announces Price Target of $70
Maintaining Hold on Solventum: A Cautious Outlook on Long-Term Turnaround and Growth Prospects
Analysts' Opinions Are Mixed on These NA Stocks: Boundless Bio Inc. (BOLD) and Solventum Corporation (SOLV)
Maintaining Hold on Solventum Corp Amidst Conservative Growth Projections and Ongoing Litigation Uncertainty
Solventum Analyst Ratings
Morgan Stanley Initiates Coverage On Solventum With Equal-Weight Rating, Announces Price Target of $70
Solventum (SOLV.US) was covered for the first time by Wells Fargo and was given a wait-and-see rating, with a target price of $69.00.
Solventum Analyst Ratings
Wells Fargo Initiates Coverage On Solventum With Equal-Weight Rating, Announces Price Target of $69
RBC Cuts Price Target on 3M to $78 From $84 to Reflect Spinoff of Solventum, Keeps Underperform Rating
Solventum Analyst Ratings